相关实验视频

Updated: Jan 8, 2026

Assembly and Purification of Prototype Foamy Virus Intasomes

Assembly and Purification of Prototype Foamy Virus Intasomes

Published on: March 19, 2018

与病毒DNA的Pi-pi堆叠相互作用有助于基于纳夫西里丁的HIV-1整合酶抑制剂的有效性

Xue Zhi Zhao¹, Min Li², Steven J Smith¹

¹Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, United States.

NAR molecular medicine

|December 22, 2025

概括

基于纳夫胺的新型整合酶链转移抑制剂 (INSTIs) 对抗HIV-1耐药突变表现出强烈的活性. 这些化合物为克服治疗耐药性和提高患者抗病毒疗效提供了一个有希望的策略.

科学领域:

药用化学医学化学
结构生物学结构生物学
病毒学病毒学

背景情况:

药物耐药性,特别是整合链转移抑制剂 (INSTIs),是HIV-1治疗的一个主要挑战.
在联合抗逆转录病毒疗法中,INSTIs至关重要,但与耐药性相关的突变限制了它们的有效性.

研究的目的:

合成基于纳胺的新型INSTI,对抗耐药性HIV-1变体的疗效提高.
阐明这些新化合物的增强抗病毒活性背后的结构和分子机制.

主要方法:

合成含有特定功能组的纳夫胺基化合物.
对流行HIV-1突变的耐药性概况的评估.
高分辨率冷电子显微镜 (cryo-EM) 用于确定结构复杂物.
分子动力学 (MD) 模拟和量子/分子力学 (QM/MM) 计算.

主要成果:

与现有FDA批准的药物相比,基于纳二的新型INSTIs在对抗关键耐药突变方面表现出同等或更高的疗效.
化EM结构揭示了与病毒DNA的增强相互作用,归因于优化的DNA堆叠.
计算分析确定了关键的分子相互作用,包括分子内键和电荷分布,控制强效药物结合.

结论:

开发的基于纳夫胺的INSTI代表了一种有前途的新类抗病毒药物,可以有效地对抗抗性HIV-1菌株.
了解增强结合的分子机制为设计下一代HIV-1抑制剂提供了基础.
这项研究提供了一种新的策略来打击HIV-1药物耐药性,改善治疗结果.

更多相关视频

Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors

Published on: January 19, 2015

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Size and Structure of Viral Genomes

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...

Viral Structure

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...